ClinicalTrials.gg
CompletedNCT07089914HAW_HS2025Updated Sep 25, 2026

Health Surveillance at University of Applied Science Hamburg (HAW)

An observational study in Social Isolation or Loneliness, Anxiety and Anxiety Acute, sponsored by Jacobs University Bremen gGmbH. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Jacobs University Bremen gGmbH · Observational

Updated Sep 25, 2026Now CompletedEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
679
Ages
18 Years and older
Sex
All
01

Study summary

The aim of Health Surveillance 2025 is to analyze and describe the state of health of employees at University of Applied Science Hamburg, key influencing factors and individual resources.

Read the detailed description

The aim of Health Surveillance 2025 is to analyze and describe the state of health of students at University of Applied Science Hamburg (HAW), key influencing factors and individual resources. In areas where there is a need for action, the Health Surveillance can provide detailed insights and/or in-depth analyses. The Health Surveillance thus provides information on health-related topics and delivers scientifically sound information as a basis for health-promoting discussions in the subsequent follow-up process at various levels (e.g. faculties). In addition, the Health Surveillance 2025 at University of Applied Science Hamburg contributes to comparability with surveys at other German universities through the use of validated and standardized measuring instruments.

Main hypotheses are

  1. The Health Surveillance 2025 gives insights into state of health of employess at HAW, key influencing factors and individual resources.
  2. With the Health Surveillance 2025 the health-promotion at HAW can be guided and promotion of mental health (including the reduction of loneliness and discrimination) can be strengthened.
  3. The health of employees, their perceived loneliness and discrimination/minorization (disadvantage) interrelates with participation in health promoting activities?
  4. Recommendations can be derived for qualification and skills training of multipliers for health-promoting behavior (e.g., MHFA-peers)?
02

Conditions studied

  • Social Isolation or Loneliness
  • Anxiety
  • Anxiety Acute
  • Anxiety Depression
  • Health Behavior
  • Health Behavior Change
  • Observational Study
  • Working Adults
  • Conditions Influencing Health Status
  • Anxiety Depression (Mild or Not Persistent)
  • Social Isolation

Keywords

  • Healthy employees
  • Health literacy
  • Disability
  • Age
  • Gender
  • work characteristics
  • PHQ-4
  • Self-efficacy
  • Satisfaction with Life Scale (SWLS)
  • Subjective health status
  • Job satisfaction
  • UCLA-LS
  • HEI-Stress
03

In context

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's enrollment of 679 is above the median of 200 across 35 observational studies indexed under Social Isolation.

Browse Social Isolation studies →

Lead sponsor

Jacobs University Bremen gGmbH is the lead sponsor of 15 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All University of Applied Sciences Hamburg employees who wish to take part in the study will be included. Inclusion criteria are germanEnglish language, reading and writing skills, internet access and employee status. Before the start of the survey period and directly before the start of the online survey, all participants will receive all relevant study information and actively declare their consent to participate in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • German language skills
  • Reading and writing skills
  • Internet access
  • Employee status
  • Consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Illiteracy
  • Massively limited cognitive abilities i.e. linguistic components of the digital offerings must be able to be used, and questionnaires completed, or interviews participated in)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
679 participants (actual)
Patient registry
No

Groups and cohorts

  • employees

    employees at University of Applied Science

06

What researchers measure

Primary outcomes

  1. Health literacy

    10 Items (Lenartz, Söllner \& Rudinger, 2014), Range 1 (does not apply/trifft überhaupt nicht zu) - 4 (does fully apply/trifft genau zu), higher scores mean a better outcome

    Time frame: baseline

  2. Loneliness

    University of California Los Angelese Loneliness Scale (UCLA-LS) - 3 Items (Schobin, Arriagada \& Gibson-Kunze, 2024), Range 1 (never/nie) - 5 (very often/sehr oft), higher scores mean a worse outcome

    Time frame: Baseline

Secondary outcomes

  1. Depression and anxiety

    Patient Health Questionnaire (PHQ-4) - 4 Items (Kroenke, Spitzer, Williams \& Löwe, 2009), Range 0 (not at all/überhaupt nicht) - 3 (nearly every day/beinahe jeden Tag), higher scores mean worse outcome

    Time frame: baseline

  2. Subjective health status

    1 Item (WHO, 1996); Range 1 (very good/sehr gut) - 5 (very poor/schlecht), higher score means worse outcome

    Time frame: baseline

  3. Job satisfaction

    Student satisfaction - 4 Items (Westermann, Heise, Spies \& Trautwein, 1996), Range 0 (not at all satisfied/gar nicht zufrieden) - 100 (completely satisfied/vollkommen zufrieden), higher scores mean better outcome

    Time frame: baseline

  4. HEI-Stress

    Higher Education Institution Stress (HEI-Stress) - 3 Items (Schmidt, Sieverding, Scheiter \& Obergfell, 2013), Range 0 (not at all stressed/gar nicht gestresst) - 100 (very stressed/sehr gestresst), higher scores mean worse outcome

    Time frame: baseline

  5. Self-efficacy

    5 Items (Jerusalem \& Schwarzer, 1999), Range 1 (not at all true/ stimmt nicht) - 4 (exacty true/ stimmt genau) higher scores mean better outcome

    Time frame: baseline

  6. Health behaviour

    3 Items (Burian, Lehnchen, Deptolla, Heinrichs \& Stock, 2023) - Range 0 (0 day/ 0 Tage) - 6 (7 days/ 7 Tage) \& 1 (I don't eat any fruits or vegetables/ Ich esse keine Früchte oder Gemüse) - 4 (5 portions or more/ 5 Portionen oder mehr) - higher scores mean better outcome

    Time frame: baseline

  7. University in transition

    7 Items (Burian, Lehnchen, Deptolla, Heinrichs \& Stock, 2023) - Range 1 (exactly true/ trifft sehr zu) - 4 (not at all true/ trifft überhaupt nicht zu) - higher scores mean worse outcome

    Time frame: baseline

Other outcomes

  1. Discriminiation

    1 Item (SOEP-IS Group, 2022) Range 1 (yes/ ja) - 2 (no/ nein) \& 1 Item (DZHW, 2022) multiple choice

    Time frame: baseline

  2. Corporate Culture (MOLA)

    20 Items (Unfallkasse Bahn Bund) - Range 1 (not at all true/ trifft überhaupt nicht zu) - 4 (exactly true/ trifft sehr zu) - higher scores mean better outcome

    Time frame: baseline

07

Study locations

1 site
  • Hamburg University of Applied Sciences/Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg)
    Hamburg, 21033, Germany
08

References and documents

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Jul 2025, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2025
First posted
Jul 29, 2025
StartActual
May 14, 2025
Primary completionActual
Jul 30, 2025
CompletionActual
Dec 31, 2025
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Sep 25, 2026
Enrollment
700 (estimated)→679 (actual)
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Active, not recruiting→Completed
    Enrollment 700 (estimated)→679 (actual)
    + 4 other changes: identifiers, verification date, date precision and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07089914
Lead sponsor
Jacobs University Bremen gGmbH
Collaborators
Hamburg University of Applied Sciences
Responsible party
Sponsor
First posted
Jul 29, 2025
Start date
May 14, 2025
Primary completion
Jul 30, 2025
Completion
Dec 31, 2025
Last update
Sep 25, 2026

Study contacts

Sonia Lippke, Prof. Dr.
principal investigator · Constructor University Bremen gGmbH & HAW Hamburg

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion